strategic initiatives

ISPE Funded Manuscripts Initiative

 

ISPE Funded Manuscript Submissions for the 2026-2027 Cycle

We are pleased to share that the ISPE Funded Manuscripts Program will reopen for the 2026–2027 annual cycle. The temporary pause in funding has been removed, and ISPE is accepting submissions through October 7, 2026. We encourage members and authorship groups to submit proposals for consideration in the 2026–2027 cycle. Please review this document for more details about format and content. 

The ISPE funded manuscripts program continues to provide an important opportunity to support impactful work that may contribute to guideline development, reference documents, and the advancement of pharmacoepidemiology.

ISPE remains deeply committed to supporting high-quality pharmacoepidemiology research and advancing work that informs practice, policy, and the broader scientific community.

Manuscript Topics

For this cycle, we welcome manuscript proposals in areas of high priority, including:

  1. Pharmacoepidemiology and critical global issues
  2. Patient-centered risk communication
  3. Health-data interoperability
  4. Embedding patient-reported outcomes in real-world evidence research
  5. AI, including generative AI, and ML methods for causal inference
  6. Precision medicine and pharmacogenomics
  7. Multi-database or multi-region pharmacoepidemiology studies

Additional topics, including emerging issues, best practices, and guidance on methods in pharmacoepidemiology, regulatory decision-making, or translating evidence into policy, may also be considered.

Manuscript proposals that are selected for funding will go through the ISPE endorsement process, which provides formal recognition, increases the visibility and impact of the work, and offers valuable peer feedback to support high-quality scholarly contributions. In alignment with the ISPE Strategic Plan 2024–2029, Goal 8.2 (Tactic #5), ISPE also encourages sponsored manuscripts to include identified external partners and, where appropriate and applicable, non-ISPE members as co-authors.

The official call for proposals, including the submission link and instructions for proposal development, is linked below. The deadline to submit the proposals is October 7 at 11:59 PM EDT.

We encourage members and authorship groups to submit proposals for consideration in the 2026–2027 cycle. The ISPE funded manuscripts program continues to provide an important opportunity to support impactful work that may contribute to guideline development, reference documents, and the advancement of pharmacoepidemiology.

We look forward to reviewing submissions and continuing to support meaningful scholarship across our community.

Best regards,

Mehmet Burcu, FISPE
Chair, Public Policy Committee

Submit a Funded Manuscript Proposal

 

We continue to encourage members to submit manuscripts for ISPE endorsement.

Why submit for endorsement? 

  • Gain formal recognition from ISPE 

  • Increase impact and visibility of your work 

  • Receive valuable feedback through ISPE’s peer review process 

Learn more about the endorsement process

Let’s continue shaping the future of pharmacoepidemiology—together.